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Abstract
Background: Expansion of the CGG trinucleotide repeat in the 59-untranslated region of the FMR1, fragile X mental
retardation 1, gene results in suppression of protein expression for this gene and is the underlying cause of Fragile X
syndrome. In unaffected individuals, the FMRP protein, together with two additional paralogues (Fragile X Mental
Retardation Syndrome-related Protein 1 and 2), associates with mRNA to form a ribonucleoprotein complex in the nucleus
that is transported to dendrites and spines of neuronal cells. It is thought that the fragile X family of proteins contributes to
the regulation of protein synthesis at sites where mRNAs are locally translated in response to stimuli.
Methodology/Principal Findings: Here, we report the X-ray crystal structures of the non-canonical nuclear localization
signals of the FXR1 and FXR2 autosomal paralogues of FMRP, which were determined at 2.50 and 1.92 A ˚, respectively. The
nuclear localization signals of the FXR1 and FXR2 comprise tandem Tudor domain architectures, closely resembling that of
UHRF1, which is proposed to bind methylated histone H3K9.
Conclusions: The FMRP, FXR1 and FXR2 proteins comprise a small family of highly conserved proteins that appear to be
important in translational regulation, particularly in neuronal cells. The crystal structures of the N-terminal tandem Tudor
domains of FXR1 and FXR2 revealed a conserved architecture with that of FMRP. Biochemical analysis of the tandem Tudor
doamins reveals their ability to preferentially recognize trimethylated peptides in a sequence-specific manner.
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Introduction
Fragile X syndrome (FXS) is one of the most common
inherited developmental disorders that is estimated to affect one
in 4000 males and one in 8000 females[1]. Clinically, affected
individuals face a broad range of intellectual and physical
challenges, including IQ scores ranging between 20 and 70, mild
abnormal facial features and macroorchidism in prepubescent
males[2]. The underlying cause of FXS has been mapped to a
large expansion of the CGG trinucleotide repeat in the 59-
untranslated region of the FMR1, fragile X mental retardation 1[3].
The typical repeat size in healthy individuals ranges from 7 to 40,
but is expanded to more than 230 and exhibits abnormal
hypermethylation in cases of the full mutation. Mutation in other
areas of the FMR1 gene have also been correlated with similar
clinical presentation[4].
FMRP, Fragile X Mental Retardation Protein, and its
autosomal paralogues, FXR1 and FXR2 (Fragile X mental
Retardation Syndrome-related Protein 1 and 2, respectively),
comprise a family of RNA-binding proteins[5,6]. These proteins
are highly similar to one another, exhibiting a sequence identity of
greater than 60%, and also retain highly conserved domain
architectures. The two ribonucleoprotein K homology domains
(KH domains) and the cluster of arginine and glycine residues that
constitute the RGG box, comprise a large region that is important
for RNA binding and polyribosome association[7,8]. FMRP has
been shown to play an important role in translation control, both
in vivo and in vitro[9,10,11]. Thus far, the wealth of data associated
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target mRNA in the nucleus to form a ribonucleoprotein complex
which is transported to dendrites and spines. Here, FMRP is
involved in the regulation of protein synthesis at sites where
mRNAs are locally translated in response to stimuli[12]. FMRP
has also been shown to interact with components of the miRNA
pathway, including RISC proteins (reviewed in[13]).
While FMRP exhibits predominant cytoplasmic localization,
data from a variety of sources have pointed to an ability of FMRP
to shuttle into the nucleus[14,15]. Immunogold staining has
identified FMRP in the neuronal nucleoplasm and within nuclear
pores
15. In both Xenopus tropicalis and zebrafish embryos, FMRP is
predominantly localized to the nucleus early in develop-
ment[16,17]. This altered localization has been correlated with
periods in which no zygotic transcription is detectable, suggesting
that the export of FMRP, and its paralogues, from the nucleus is
dependent on mRNA synthesis[18]. More recently, the functional
and physical association of FMRP with the primary RNA exporter
Tab/NXF1, and with the active transcription units of the
lampbrush chromosomes in amphibian oocytes, has provided the
first direct lines of evidence of FMRP-mRNA associated within the
nucleus[19].
The N-terminal region of FMRP, and the FXR1 and FXR2
paralogues, contains a nuclear localization signal between residues
1 and 184[8,20,21]. Prior structural studies of the FMRP protein
identified a repeat of two domains within the NLS region that each
closely resembles the Tudor domain of the SMN protein[22].
NMR-based titrations with
15N-labelled protein corresponding to
the NLS region also suggested its ability to interaction with
trimethylated substrates, though this was assessed only from
binding assays with individual amino acids carrying single post-
translational modifications[22]. In this work, we present the crystal
structures of the NLS of the FXR1 and FXR2 paralogues and
definitively classify this region as a member of the Royal Family
comprising a tandem Tudor repeat. Extensive structural and
biochemical analyses also suggest that this region recognizes tri-
methylated protein substrates in a sequence-specific manner
common to both paralogues.
Results
The NLS of FXR1 and FXR2 comprises a tandem Tudor
domain
The crystal structures of residues 4 to 122 of the FXR1
(Figure 1A) and residues 13 to 136 of the FXR2 protein (Figure 1B)
were determined at 2.5 and 1.92 A ˚, respectively (Table 1). Each
structure was elucidated by the single anomalous dispersion (SAD)
technique using a selenomethionine-substituted derivative. Super-
position of the FXR1 and FXR2 tandem Tudor domains
structures yields excellent alignment with a 1.0 A ˚ r.m.s.d.
(Figure 1C) and a sequence identity of 79% for the aligned
regions (Figure 1E).
Alignment of the full tandem Tudor architecture with the N-
terminal region of FMRP (Figure 1D, PDB 2BDK), which was
previously determined by nuclear magnetic resonance experi-
ments, reveals a highly conserved structural architecture with only
2A ˚ r.m.s. deviation when the tandem Tudors of either FXR1 or
FXR2 are used for alignment. Minor deviations are observed only
in the conformations of the highly flexible loops between all three
paralogues, with little deviation observed in the assembly of the
individual Tudor domains or the relative orientation of the N- and
C-terminal Tudors (Figure 1).
The N-terminal Tudor domain (Tud1) spans residues 2 to 49 of
FXR1 and residues 13 to 56 of the FXR2 protein. The Tud1
domain forms a canonical Tudor barrel that comprises five highly
twisted antiparallel b-strands with a single 310 helix residing
between strands b4 and b5. Alignment of the Tud1 domains of
FXR1 and FXR2 yields a 1.07 A ˚ r.m.s deviation with 79%
sequence identity. Structural comparison of the Tud1 domain with
other proteins of known structure was performed with the
Secondary Structure Matching server (SSM). The Tud1 domains
from both FXR1 and FXR2 align well with the C-terminal DNA-
binding domain of the HIV-1 integrase (Figure 2A, PDB 1qmc),
for which the root mean square deviations are 1.49 and 1.3,
respectively (Figure 2). Good structural alignments with r.m.s.
deviations between 0.8 and 2 A ˚ are also obtained for alignments
with other Tudor domains, including those of PHF1 (PDB 2e5p),
PHF19 (Figure 2B, PDB 2e5q), and the survival of motor neuron
(SMN) protein (Figure 2C) PDB 1g5v).
The C-terminal Tudor (Tud2) domains of FXR1 and FXR2
yield a 1.08 A ˚ r.m.s.d. on alignment with a 79% sequence
identity for the aligned residues. These domains also show a high
degree of structural homology with Royal Family member
proteins, including the SMN protein (PDB 1g5v), PHF19
(2e5q), and the HIV-1 integrase binding domain (PDB 1ihv)
(Figure 2). Good agreement was also observed on alignment with
the malignant brain tumor repeat (MBT) domain of PHF20L1
(PDB 2jtf) and the metal response element-binding transcription
factor 2 (PDB 2eqj). All alignments yielded r.m.s. deviations
below 2 A ˚.
Alignment of the Tud1 with Tud2 for each of the paralogues
also reveals a high degree of structural conservation between the
individual Tudor domains (1.4 A ˚ r.m.s.d.). However, while
structurally the Tudors are very similar, the Tud1 domains
exhibit much great sequence conservation with one another than is
observed between the Tud 1 and Tud2 from a single protein.
Sequence alignments of Tud1 with Tud2 result in 14% sequence
and 17% identity between the Tudor domains of FXR1 and
FXR2, respectively (data not shown).
The tandem Tudor domain closely resembles that of
UHRF1
The tandem arrangement of the FXR Tudor domains closely
resembles that observed in the crystal structure of the E3
ubiquitin-protein ligase UHRF1 (PDB 3db4) (Figure 2D). The
alignment of FXR1 with UHRF1 produces a 2.8 A ˚ r.m.s.d, while
that of FXR2 with UHRF1 results in a 2.5 A ˚ r.m.s.d. The
sequence identities are 12% and 11%, respectively, for the aligned
regions.
The Tudor domains utilize a highly charged interface for
association
While prior structural work also demonstrated the existence of
two Royal Family domains within the nuclear localization signals of
the FMRP paralogues, this crystallographic analysis has permitted
the high resolution visualization of the interface between the
individual Tudor domains for both FXR1 and FXR2 (Figure 3).
The Tudor domains tilt toward one another to generate an
interdomain angle of approximately 110u. Interaction between
Tud1 and Tud2 creates an interface of 257.5 A ˚ 2 for FXR1 and
258.9 A ˚ 2 for FXR2. The orientation is stabilized in FXR1 by an
ionic lock formed by inter-domain salt bridges between E6 and R47
from Tud1 and E65 and R112 from Tud 2 (Figure 3A). The
corresponding residues for FXR2 are E17 and R58 from Tud1 and
E76 and R123 from Tud2 (Figure 3B). Hydrogen bonds between
the mainchain atoms of F14 from Tud1 (F25 in FXR2) and W78
(W89 in FXR2) of Tud2 lend further stability to this region. Finally,
FXR1 and FXR2
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V125 to A131 in FXR2), which fold back along the base of the
tandem Tudor domains toward the N-terminus, engages in
extensive interactions with the intervening segment that tethers
the individual Tudor domains. This results in the formation of
several hydrogen bonds that assist in anchoring of the relative
orientations of the domains. No ionic lock is visible in the NMR
structure of the FMRP protein (Figure 3C), though the relevant
residues are strictly conserved (Figure 1D), suggesting some degree
of flexibility in the inter-domain orientation.
Figure 1. The crystal structures of FXR1 (A) and FXR2 (B) reveal a shared tandem Tudor domain architecture. Tud 1 domains are
colored in cyan and Tud2 domains in magenta. Coiled regions are indicated in grey. The residues forming the aromatic cage of Tud2 are shown as in
stick representation and are colored yellow. (C) FXR1 (cyan) and FXR2 (purple) align well and reveal a conserved interdomain orientation. (D The
previously determined structure of FMRP (PDB 2BDK) also comprises the tandem Tudor architecture. The coloring is as described for the FXR1 and
FXR2 panels. (E) The sequence alignment of the FXR proteins. Residues are colored in agreement with the b-strands of panels A, B, and D. Residues in
bold correspond to the ionic lock, underlined residues exhibit alterations in the HSQC spectra on peptide titration, and the asterisks denote strictly
conserved residues.
doi:10.1371/journal.pone.0013559.g001
FXR1 and FXR2
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ofUHRF1ishighlysimilartothat oftheFragile X paraloguesand is
also stabilized by salt bridge formation between residues R205 and
D240 (Figure 3D). Extensive interactions between the C-terminal
tail of the UHRF1 tandem Tudor with the segment joining the
individualTudordomainsisalsoretained,suggestingthatthesemay
be important features in the organization and structural stability for
this arrangement of tandem Tudor domains.
FXR1 and FXR2 recognize peptides in a sequence-specific
and PTM-specific manner
Royal family members have been widely studied for histone
modification mark recognition[23,24,25,26,27]. The ability of the
FXR1 and FXR2 paralogues to interact with peptides derived
from histone tails carrying various post-translational modifications
was assessed by fluorescence polarization assay. Titration of the
tandem Tudor domains initially indicated potential interactions
with H3K4me3, H3K9me3 and H4K20me3 (data not shown).
Therefore, a systematic binding study was undertaken to assess the
preferences of FXR1 and FXR2 for the varying methylation states
at these lysine sites. The sequences of the peptides used in this
study, along with their respective binding affinities are reported in
Table 2. Both FXR1 and FXR2 proteins exhibit preference for
trimethylated peptides over lower methylated lysine peptides of
H4K20 (Figure 4 and Table 2). Reduced preference for
trimethylation was also observed for interaction of the tandem
Tudor domains of FXR1 and FXR2 with H3K4 or H3K9
peptides (data not shown). Furthermore, FXR2 shows some degree
of preference for H4K20me3 peptide (Table 2). No detectable
binding was detected for other H3- or H4-derived peptides
(Table 2).
NMR and molecular docking simulations suggest the
Tud2 aromatic cage to be the site of ligand recognition
In agreement with the fluorescence polarization data, the
addition of 1.5 molar excess of H4K20me3 peptide resulted in
specific chemical shifts in the
15N-HSQC NMR spectrum of
FXR2 (Figure 5A–D). The chemical shifts are quite similar to
those reported for the titration of FMRP with trimethylated
lysine[22]. Molecular docking simulations permitted the place-
ment of trimethylated lysine in this site in a conformation
consistent with the observed chemical shift (Figure 5E).
Discussion
The FMRP, FXR1 and FXR2 proteins comprise a small family
of highly conserved proteins that appear to be important in
translational regulation, particularly in neuronal cells. The crystal
structures of the N-terminal tandem Tudor domains of FXR1 and
FXR2 were determined at 2.50 A ˚ and 1.92 A ˚, respectively, and
revealed a conserved architecture as compared with the same
region of FMRP. Biochemical analysis of the FXR1 and FXR2
proteins suggested that both proteins preferentially recognize
trimethylated histone peptides (Table 2).
The interaction of FMRP with trimethylated lysine residues was
initially demonstrated via NMR titration, but not in the context of
histone-derived peptides[22]. This interaction was of low affinity
and required titration with 20-fold molar excess of ligand to induce
specific amide resonance shifts for a pocket located in the second
Tudor domain. The residues defining this pocket (Y95, W97, V66,
and E104 for FXR1) are strictly conserved amongst the Fragile X
paralogues. NMR titration experiments carried out for FXR2
resulted in similar shifting with only 1.5-fold molar excess of
H4K20me3 peptide suggesting a specific interaction of higher
affinity than for the methylated lysine alone.
Structural alignment of the tandem Tudors from the fragile X
family revealed excellent conservation of the tandem Tudor
assembly with that of the UHRF1 protein, for which crystallo-
graphic analysis has suggested an affinity for H3K9me3 (PDB
3db3). Despite the conservation of domain architecture, however,
structural analysis of the interaction of H3K9me3 with the
UHRF1 Tudor domains revealed Tud1 to be the module
responsible for the recognition of this peptide. Analogous to the
Table 1. Crystallographic and refinement statistics.
Data Collection
FXR1 FXR2
Wavelength (A ˚) 0.979 0.979
Space Group R3 P212121
Unit Cell Parameters (A ˚) a=71.9
b=71.9
a=34.6
b=54.7
c=94.1 c=70.17
Resolution (A ˚) 50-2.50 100-1.92
(2.59-2.50) (1.96-1.92)
a
Reflections
Unique 6291 (643) 10551 (533)
Completeness (%) 99.9 (100) 99.0 (87.0)
Redundancy 4.0 (3.9) 6.1 (2.5)
I/s(I) 11.3 (1.7) 24.2 (1.5)
Rsym (I)
b 0.074 (0.547) 0.09 (0.96)
Refinement
Resolution (A ˚) 35.93-2.50 43.11-1.92
Reflections
Number 6000 10430 (589)
Completeness (%) 99.9 (99.6) 100 (80)
Test Set (%) 4.6 4.5
Rwork 21.8(21.0) 0.21 (0.26)
Rfree 26.1 (46.8) 0.25 (0.34)
E.S.U. (A ˚)
c 0.205 0.103
Contents of A.U.
d
Protein Molecules/Atoms 1/805 1/873
Solvent 1 63
Mean B-Factors (A ˚2) 32.05
Protein 68.1 20.5
Ramachandran Plot (%)
Preferred 95.7 99.0
Allowed 4.3 1.0
Outlier 0 0.0
RMSD
e from Target Geometry
Bond Lengths (A ˚) 0.017 0.021
Bond Angles (u) 1.760 1.729
PDB ID 3O8V 3H8Z
aData for the highest resolution shell in parenthesis.
bRsym(I)=ghklgi|I i(hkl) - ,I(hkl).|/ghkl gi |I i (hkl)|; for n independent
reflections and I observations of a reflection; I(hkl).-average intensity of the I
observations.
cE.S.U. – estimated overall coordinate error based on maximum likelihood.
dA.U. – asymmetric unit.
eRMSD – root mean squared deviation.
doi:10.1371/journal.pone.0013559.t001
FXR1 and FXR2
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UHRF1 also comprises both aromatic (Phe, and Tyr) and polar
(Asp and Asn) residues. For all these four proteins, each Tudor
domain appears to possess pockets that may potentially recognize
post-translation modifications on a single substrate, though
multivalent interaction of tandem Tudor domains in this structural
arrangement has yet to be demonstrated.
It has been previously demonstrated that FMRP becomes
associated with its cargo mRNAs in the nucleus in a manner that is
dependent on the presence of a non-classical nuclear localization
signal (NLS)[19]. Removal of the NLS was also shown to
compromise RNA binding, as well as association of the FMRP
protein with its autosomal paralogue FXR1[19]. The ability of the
Fragile X proteins to recognize methyl marks in a sequence-
dependent fashion may suggest an involvement of methyllysine
recognition in targeting these proteins within the nucleus, either to
newly synthesized transcripts or in recognition of other compo-
nents of FXR-mRNA complex that are also methylated. Clearly,
elucidation of the in vivo function of the tandem Tudor domains of
the FXR paralogues will be a critical component for modeling the
roles of these proteins in mRNA trafficking and associated disease
pathologies.
Materials and Methods
Cloning, expression and protein purification
DNA sequences corresponding to amino acids 2 to 132 of
FXR1 and 14 to 137 of FXR2 were subcloned into the pET-28a-
MHL vector via ligase-independent cloning. Recombinant His6-
TEV-FXRs were expressed in a SGC-generated derivative strain
of BL21 Escherichia coli with the pRARE plasmid for codon biased
expression. Cells were grown in minimal media supplemented
with selenomethionine (Molecular Dimensions Inc, Apopka, FL) in
the presence of kanamycin and chloramphenicol at 37uCt oa n
optical density of approximately 2.5. Protein expression was
induced with 1 mM isopropyl-1-thio-D-galactopuranoside and the
cell cultures continued for approximately 16 hours at 15uC. The
cells were harvested via centrifugation and the resultant pellet
stored at -80uC prior to purification.
The cell pellet from a 2 L culture was resuspended in 200 mL of
lysis buffer consisting of PBS pH 7.2–7.5 (Bioshop, Burlington,
ON), 250 mM NaCl, 5% glycerol, 10 mM b-mercaptoethanol,
1 mM PMSF, 5 mgm L
21 Benzonase, 0.2% CHAPS. The
homogenized suspension was lysed via sonication and insoluble
material removed via centrifugation. The clarified supernatant was
Figure 2. Structural similarity of the Fragile X Tudor domains with other b-barrel proteins. 3D Structures of: (A) the DNA binding domain
of the HIV-1 integrase (PDB 1IHV); (B) the Tudor domain of the PHD finger protein 19 (PDB 2E5Q); (C) the Tudor domain of the human SMN protein
(PDB 1G5V). These three structures are shown in the same orientation based on superposition. (D) Crystal structure of FXR2 is shown for comparison.
The first Tudor (tud1) is colored in cyan and the second Tudor (tud2) is colored in purple.
doi:10.1371/journal.pone.0013559.g002
FXR1 and FXR2
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had been pre-equilibrated with 20 mM Tris-Cl pH 8.0, 500 mM
NaCl. The resin was washed with 50 column volumes of 20 mM
Tris-Cl pH 8.0, 500 mM NaCl, 10 mM imidazole. Finally, the
protein was eluted from the resin with 15 mL of 20 mM Tris-Cl
pH 8.0, 250 mM NaCl, 250 mM imidazole, 5% glycerol. Further
purity for each sample was achieved via Superdex 75 (GE
Healthcare, Tyrone, PA) size exclusion chromatography in
20 mM Tris-Cl pH 7.5, 200 mM NaCl, 1 mM DTT.
The hexahistide purification tag was cleaved from FXR1 by the
addition of 0.05 mg TEV protease per milligram of FXR1 protein,
followed by incubation at 4uC for 12 hours. The sample was then
passed over a Ni-NTA column and the flow-through collected for
crystallization. The purification tag was not removed from FXR2.
Crystallization
Crystals of diffraction quality were grown at 18uC using the
sitting drop method for FXR1 and hanging drop method for
FXR2 by mixing an equal volume of protein solution with
reservoir solution. The proteins were concentrated to 10 mg mL
21
in 20 mM Tris-Cl, pH 7.0, 200 mM NaCl and 1 mM DTT prior
to crystallization. The crystallization condition for FXR1 was
1.4 M (NH4)2SO4, 0.25 M NaCl, 0.1 M HEPES pH 6.8. FXR2
crystallized in 20–30% polyethylene glycol 3350, 0.2 M MgCl2,
0.1 M HEPES, pH 7.5. Crystals were harvested and soaked in the
crystallization condition with 20–30% glycerol prior to freezing in
liquid nitrogen.
Structure determination of FXR1
Data for FXR1 were collected at the Canadian Macromolec-
ular Crystallography Facility (CMCF) on beamline 08ID-1 at the
Figure 3. An interdomain ionic lock stabilizes the tandem Tudor architecture. The FXR1 (A) and FXR2 (B) domains are stabilized by
extensive interactions between the charged residues at this interface. While the residues are conserved in the FMRP protein (C), the NMR structure
suggested a slightly different domain orientation that results in a loss of salt bridging. (D) The UHRF1 interface is also stabilized by the formation of a
salt bridge. The ribbon traces are colored to correspond with Figure 1 and residues comprising the ionic lock are colored in yellow for all panels.
doi:10.1371/journal.pone.0013559.g003
Table 2. Binding affinities of FXR1 or FXR2 Tudor domains to
histone H3 or H4 methylated lysine peptides.
Peptides Sequences
FXR1
Kd (mM)
FXR2
Kd (mM)
H4K20 G G A K R H R K V L R D N .1m M 1 0 5 8 663
H4K20me1 G G A K R H R Kme1 V L R D N I Q 914652
H4K20me2 G G A K R H R Kme2 V L R D 633630
H4K20me3 G G A K R H R Kme3 V L R D 6926113 448619
H3K4me3 A R T Kme3 Q T A R K S T 6606121 .1m M
H3K9me3 A R T K Q T A R Kme3 S T G G K A .1m M .1m M
H3K27me3 Q L A T K A A R Kme3 S A P A No binding No binding
H3K36me3 P A T G G V Kme3 K P H R Y No binding
H3K37me3 P A T G G V K Kme3 P H R Y No binding
H3K79me3 E I A Q D F Kme3 T D L R Y No binding
doi:10.1371/journal.pone.0013559.t002
FXR1 and FXR2
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Intensities were integrated and scaled using HKL2000[28]. The
structure of FXR1 was determined using the single-wavelength
anomalous dispersion (SAD) method utilizing the anomalous
signal from selenium atoms. The positions of 2 selenium atoms
were found with the program SHELXD[29] followed by heavy
atom refinement and phasing using the maximum likelihood-
based algorithm as implemented in the auto-SHARP program
suite[30]. Phase improvement by density modification generated
an interpretable experimental SAD map, allowing an initial
model to be built using ARP/wARP[31]. Following alternate
cycles of manual building using COOT[32] and restrained
refinement using REFMAC[33], the presence of twinning was
initially suspected owing to unusually elevated R/Rfree residual
factors (.30%) and later confirmed by intensity statistics
calculations, as performed using the module phenix.xtriage[34].
Subsequent refinement in REFMAC[33] employing a merohe-
dral twin model for space group R3 with twin operators (H K L)
and (K H–L) immediately reduced R/Rfree below 30%, revealing
a minor twin fraction of 5.9%. The final model comprising one
molecule of FXR1 refined to an Rwork of 21.8% and Rfree of
26.1%.
Structure determination of FXR2
Single anomalous dispersion data were collected at the
selenium K edge at 19-ID at the Advanced Photon Source
(Chicago, IL, USA) at 100K. Data intensities were indexed and
scaled with HKL2000[28]. Heavy atom substructure determina-
tion followed by phase refinement and density modification were
carried out in SOLVE and RESOLVE[35,36], respectively.
Automated model building in ARP/wARP was utilized to
generate the initial model. Manual model improvements and
refinement were carried out in COOT[32] and REFMAC[33],
respectively.
Fluorescence polarization screening of peptide
substrates
All peptides used for fluorescence polarization (FP) and
isothermal titration calorimetry (ITC) measurements were synthe-
sized by Tufts University Core Services (Boston, MA, USA).
Fluorescence polarization assay was performed as reported
previously[37,38]. FXR1 and FXR2 were dialyzed into 20 mM
Tris-Cl pH 8.0, 50 mM NaCl, 1 mM DTT and concentrated to
18.2 mg mL
21 (1.03 mM) and 39.2 mg mL
21 (2.4 mM) respec-
tively. Serial twofold dilutions were then made to produce 25 mlo f
K, J, 1/8, 1/16, 1/32, 1/64, 1/128, 1/256, 1/512, 1/1024
diluted samples. Buffer without protein was used as blank control.
The fluoresceinated peptides H3K4Me3, H3K9Me3,
H3K27Me3, H4K20Me3 and H4K20Me0 were each added to
above samples to a final concentration of 100 nM. Samples were
incubated at room temperature for 30 minutes and centrifuged
prior to use. The anisotropy of the sample was recorded with a
Synergy 2 Multi-Mode microplate Reader (BioTek, Winooski,
VT)). The reported polarization value was fit and plotted by
Origin 6.1 (OriginLab, Northampton, MA).
NMR titrations of histone derived peptides
Preparation of isotopically labeled FXR2 Tudor domain
followed similar purification steps as above except that instead of
LB media, M9 media containing 1 g/L
15NN H 4Cl, 4 g L
21
[
12C6]-D glucose was used. To investigate the binding of FXR2
Tudor domain to methylatd histone peptides,
15N-
1H HSQC
spectra were collected with
15N-labeled FXR2 samples, free and
with additions of increasing amounts of unlabeled histone
peptides. All NMR experiments were performed at 298K with
Bruker Avance 500 MHz spectrometers equipped.
15N-FXR2 was
concentrated to 0.3 mM, prepared in 20 mM NaH2PO4, pH 6.7,
50 mM NaCl, 1 mM EDTA, 1 mM DTT, and 93% H2O/7%
D2O.
Figure 4. FXR1 and FXR2 preferentially recognizes trimethylated histone peptides. The fluorescence polarization binding curves for FXR2
and H4K20 peptides are shown as a example.
doi:10.1371/journal.pone.0013559.g004
FXR1 and FXR2
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e13559Figure 5. Recognition of trimethylated lysine by the Tud2 domain of FXR2. (A) Superposition of the HSQC spectra for the tandem Tudor
domains of FXR2 in the presence (cyan) and absence (magenta) of the 1.5 molar excess H4K20me3 peptide. (B) HSQC spectra for FMRP reported in
refenrence 22. (C) and (D) Specific chemical shifts corresponding to the predicted binding site for trimethylated lysine in FXR2-Tud2. (E) A model of
trimethylated lysine recognition by FXR2-Tud2. Residues present in the crystal structure and that yield chemical shifts during titrations are indicated.
doi:10.1371/journal.pone.0013559.g005
FXR1 and FXR2
PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e13559Docking of trimethylated lysine in the FXR2 aromatic
cage. Docking simulations using trimethylated-lysine were
carried out in AutoDock 4.2 with AutoDockTool-1.5.4. Static
coordinates for the ligand binding site residues were employed and
the docking carried out using the genetic algorithm. Default
docking parameters were utilized. Clusters were scored and the
lowest energy conformational clusters analyzed.
Supporting Information
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